Showing 1 - 12 results of 12 for search 'Peiguo Cao', query time: 0.06s Refine Results
  1. 1
    EphA2 modulates radiosensitive of hepatocellular carcinoma cells via p38/mitogen-activated protein kinase-mediated signal pathways

    EphA2 modulates radiosensitive of hepatocellular carcinoma cells via p38/mitogen-activated protein kinase-mediated signal pathways by Qiao Jin, Xiangjun Li, Peiguo Cao

    Published 2015-10-01
    Get full text
    Article
  2. 2
    Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis

    Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis by Ziying Zhang, Peng Chen, Hui Xie, Peiguo Cao

    Published 2020-02-01
    Get full text
    Article
  3. 3
    Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma

    Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma by Ziying Zhang, Peng Chen, Hui Xie, Peiguo Cao

    Published 2021-03-01
    Get full text
    Article
  4. 4
    A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3X

    A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3X by Yuliang Pan, Yuxing Zhu, Jun Zhang, Long Jin, Peiguo Cao

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Primary breast angiosarcoma: A case report

    Primary breast angiosarcoma: A case report by Yu He, Liyuan Qian, Lang Chen, Yang Liu, Yanguang Wen, Peiguo Cao

    Published 2023-02-01
    Get full text
    Article
  6. 6
    ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis

    ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis by Xuan Wang, Honghua Peng, Ganghua Zhang, Zeyuan Li, Zhangyan Du, Bin Peng, Peiguo Cao

    Published 2023-07-01
    Get full text
    Article
  7. 7
    lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity

    lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity by Qiao Jin, Hao Hu, Siqi Yan, Long Jin, Yuliang Pan, Xiangjun Li, Yayi Peng, Peiguo Cao

    Published 2021-02-01
    Get full text
    Article
  8. 8
    A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort

    A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database... by Gouling Zhan, Honghua Peng, Lehong Zhou, Long Jin, Xueyi Xie, Yu He, Xuan Wang, Zhangyan Du, Peiguo Cao

    Published 2023-01-01
    Get full text
    Article
  9. 9
    Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism

    Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism by Li Yu, Yifan Sun, Jingjing Li, Yan Wang, Yuxing Zhu, Yong Shi, Xiaojun Fan, Jianda Zhou, Ying Bao, Jie Xiao, Ke Cao, Peiguo Cao

    Published 2017-08-01
    Get full text
    Article
  10. 10
    Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)

    Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR... by Lin Wu, Chao Deng, Hui Zhang, Jie Weng, Youhua Wu, Shan Zeng, Tiegang Tang, Peiguo Cao, Bo Qiu, Li Zhang, Huaxin Duan, Bing Zhang, Dong Zhang, Taotao Zhang, Chunhong Hu

    Published 2021-12-01
    Get full text
    Article
  11. 11
    Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis

    Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis by Honghua Peng, Guifeng Liu, Ying Bao, Xi Zhang, Lehong Zhou, Chenghui Huang, Zewen Song, Sudan Cao, Shiying Dang, Jing Zhang, Tanxiao Huang, Yuling Wu, Mingyan Xu, Lele Song, Lele Song, Peiguo Cao

    Published 2021-12-01
    Get full text
    Article
  12. 12
    Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ studyResearch in context

    Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metas... by Lin Yang, Wen Zhang, Nanfeng Fan, Peiguo Cao, Ying Cheng, Lingjun Zhu, Suxia Luo, Hong Zong, Yuxian Bai, Jianfeng Zhou, Yanhong Deng, Yi Ba, Tianshu Liu, Mayinuer Aili, Xianli Yin, Kangsheng Gu, Guanghai Dai, Jieer Ying, Jianhua Shi, Yajie Gao, Wei Li, Guohua Yu, Liangzhi Xie, Wenlin Gai, Yan Wang, Peng Meng, Yuankai Shi

    Published 2024-02-01
    Get full text
    Article

Search Tools: